This inventor holds 1 USPTO granted patent. Top assignee: Asta-Werke Aktiengesellschaft. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988
Title: Martin Schneider: Innovator in Antitumor Compounds
Introduction
Martin Schneider is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor compounds. His innovative work has the potential to impact cancer treatment positively.
Latest Patents
Martin Schneider holds 1 patent for his work on derivatives of antitumor compounds. The patent details a formula where the substituents R₁ and R₂ can represent various chemical groups, including hydrogen and different alkylaminocarbonyl groups. This invention is particularly relevant for treating estrogen-receptor-positive tumors and prostate carcinoma.
Career Highlights
Throughout his career, Martin Schneider has been associated with Asta-Werke Aktiengesellschaft, where he has focused on research and development in the pharmaceutical sector. His dedication to innovation has led to advancements in cancer treatment methodologies.
Collaborations
Martin Schneider has collaborated with esteemed colleagues, including Helmut Schonenberger and Rolf W. Hartmann. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Martin Schneider's contributions to the field of antitumor compounds exemplify the importance of innovation in medicine. His work continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile